Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer

被引:0
|
作者
Qingzhu Jia
Wei Wu
Yuqi Wang
Peter B. Alexander
Chengdu Sun
Zhihua Gong
Jia-Nan Cheng
Huaibo Sun
Yanfang Guan
Xuefeng Xia
Ling Yang
Xin Yi
Yisong Y. Wan
Haidong Wang
Ji He
P. Andrew Futreal
Qi-Jing Li
Bo Zhu
机构
[1] Third Military Medical University,Institute of Cancer, Xinqiao Hospital
[2] Chongqing Key Laboratory of Tumor Immunotherapy,Department of Cardiothorathic Surgery, Southwest Hospital
[3] Third Military Medical University,Department of Immunology
[4] Geneplus-Beijing Institute,Biomedical Analysis Center
[5] Duke University Medical Center,Department of Microbiology and Immunology, Lineberger Comprehensive Cancer Center
[6] Third Military Medical University,Department of Genomic Medicine
[7] Houston Methodist Research Institute,undefined
[8] University of North Carolina at Chapel Hill,undefined
[9] GeneCast Biotechnology Co.,undefined
[10] Ltd,undefined
[11] The University of Texas MD Anderson Cancer Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Combining whole exome sequencing, transcriptome profiling, and T cell repertoire analysis, we investigate the spatial features of surgically-removed biopsies from multiple loci in tumor masses of 15 patients with non-small cell lung cancer (NSCLC). This revealed that the immune microenvironment has high spatial heterogeneity such that intratumoral regional variation is as large as inter-personal variation. While the local total mutational burden (TMB) is associated with local T-cell clonal expansion, local anti-tumor cytotoxicity does not directly correlate with neoantigen abundance. Together, these findings caution against that immunological signatures can be predicted solely from TMB or microenvironmental analysis from a single locus biopsy.
引用
收藏
相关论文
共 50 条
  • [31] Immune checkpoint pathways in non-small cell lung cancer
    Chae, Young Kwang
    Arya, Ayush
    Iams, Wade
    Cruz, Marcello
    Mohindra, Nisha
    Villaflor, Victoria
    Giles, Francis J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
  • [32] Immune Cell Composition in Human Non-small Cell Lung Cancer
    Stankovic, Branislava
    Bjorhovde, Heidi Anine Korsmo
    Skarshaug, Renate
    Aamodt, Henrik
    Frafjord, Astri
    Mueller, Elisabeth
    Hammarstrom, Clara
    Beraki, Kahsai
    Baekkevold, Espen S.
    Woldbaek, Per Reidar
    Helland, Aslaug
    Brustugun, Odd Terje
    Oynebraten, Inger
    Corthay, Alexandre
    FRONTIERS IN IMMUNOLOGY, 2019, 9 : 3101
  • [33] Immune cell composition in human non-small cell lung cancer
    Stankovic, Branislava
    Korsmo, Heidi Anine
    Skarshaug, Renate
    Mueller, Elisabeth
    Aamodt, Henrik
    Hammarstrom, Clara
    Beraki, Kahsai
    Baekkevold, Espen
    Woldbaek, Per Reidar
    Helland, Aslaug
    Brustugun, Odd Terje
    Jahnsen, Frode
    Oynebraten, Inger
    Corthay, Alexandre
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 310 - 311
  • [34] Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
    Soria, Jean-Charles
    Marabelle, Aurelien
    Brahmer, Julie R.
    Gettinger, Scott
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2256 - 2262
  • [35] Immune Checkpoint Therapy in Non-Small Cell Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    CANCER JOURNAL, 2016, 22 (02): : 81 - 91
  • [36] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [37] Immune cell composition in human non-small cell lung cancer
    Stankovic, B.
    Korsmo, H. A.
    Mueller, E.
    Aamodt, H.
    Beraki, K.
    Baekkevold, E.
    Woldbaek, P. R.
    Jahnsen, F.
    Oynebraten, I
    Corthay, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 189 - 190
  • [38] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [39] Immune cell composition in human non-small cell lung cancer
    Stankovic, Branislava
    Korsmo, Heidi Anine
    Muller, Elisabeth
    Aamodt, Henrik
    Beraki, Kahsai
    Baekkevold, Espen
    Woldbaek, Per Reidar
    Helland, Aslaug
    Brustugun, Odd Terje
    Jahnsen, Frode
    Oynebraten, Inger
    Corthay, Alexandre
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2016, 83 (05) : 376 - 376
  • [40] Prognostic Immune Markers in Non-Small Cell Lung Cancer
    Suzuki, Kei
    Kachala, Stefan S.
    Kadota, Kyuichi
    Shen, Ronglai
    Mo, Qianxing
    Beer, David G.
    Rusch, Valerie W.
    Travis, William D.
    Adusumilli, Prasad S.
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5247 - 5256